Pharmacovigilance: The Regulatory Outlook
Quanticate looks at some of the challenges and pharmacovigilance regulations the industry faces since 2012 with the introduction of GVPs, Brexit and ICH E2B(R3)
Quanticate looks at some of the challenges and pharmacovigilance regulations the industry faces since 2012 with the introduction of GVPs, Brexit and ICH E2B(R3)
The ICH E2B(R3) update is intended to standardize the definition of the data elements used in electronic transmission of different types of ICSRs. Learn more
An infographic that looks at the history of Pharmacovigilance and its evolution over the 20th century in response to serious adverse events and patient safety
A survey result on the challenges of pharmacovigilance in early phase clinical trials and solutions to a lack of data, complicated patients and protocol design
A Quanticate blog exploring The Black Triangle symbol ▼ and Additional Monitoring in the new Pharmacovigilance legislation.
As the European Medicines Agency (EMA) Finalises the first set of Good Pharmacovigilance Practices (GVP), are you ready for the New PV Legislation?